90 related articles for article (PubMed ID: 23664367)
21. Practical issues in informed consent for transfusion.
Sazama K
Am J Clin Pathol; 1997 Apr; 107(4 Suppl 1):S72-4. PubMed ID: 9124233
[TBL] [Abstract][Full Text] [Related]
22. Current status of pharmacologic therapies in patient blood management.
Goodnough LT; Shander A
Anesth Analg; 2013 Jan; 116(1):15-34. PubMed ID: 23223098
[TBL] [Abstract][Full Text] [Related]
23. Factors influencing the adoption of blood alternatives to minimize allogeneic transfusion: the perspective of eight Ontario hospitals.
Graham ID; Alvarez G; Tetroe J; McAuley L; Laupacis A
Can J Surg; 2002 Apr; 45(2):132-40. PubMed ID: 11939657
[TBL] [Abstract][Full Text] [Related]
24. Progress notes updated: the consortium and other developments in education in complementary and integrative medicine.
Sierpina VS
Altern Ther Health Med; 2008; 14(2):20-2. PubMed ID: 18383986
[No Abstract] [Full Text] [Related]
25. 2005 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations. Part 8: Interdisciplinary topics.
International Liaison Committee on Resuscitation
Resuscitation; 2005; 67(2-3):305-14. PubMed ID: 16324994
[No Abstract] [Full Text] [Related]
26. Costs associated with blood transfusions in Sweden--the societal cost of autologous, allogeneic and perioperative RBC transfusion.
Glenngård AH; Persson U; Söderman C
Transfus Med; 2005 Aug; 15(4):295-306. PubMed ID: 16101807
[TBL] [Abstract][Full Text] [Related]
27. Saving lives and conserving blood: changing blood transfusion practices at St. John's Hospital, Springfield, Missouri.
Hover AR; Madigan K; Skidmore L; Shell D
Mo Med; 2003; 100(6):586-9. PubMed ID: 14699815
[TBL] [Abstract][Full Text] [Related]
28. The NHLBI Clinical Trials Network in transfusion medicine and hemostasis: an overview.
Dzik WH
J Clin Apher; 2006 Apr; 21(1):57-9. PubMed ID: 16619228
[TBL] [Abstract][Full Text] [Related]
29. Alternatives to blood transfusion.
Tolich DJ
J Infus Nurs; 2008; 31(1):46-51. PubMed ID: 18202559
[TBL] [Abstract][Full Text] [Related]
30. Blood management in two-stage revision knee arthroplasty for deep prosthetic infection.
Pagnano M; Cushner FD; Hansen A; Scuderi GR; Scott WN
Clin Orthop Relat Res; 1999 Oct; (367):238-42. PubMed ID: 10546621
[TBL] [Abstract][Full Text] [Related]
31. Consensus statement: using epoetin alfa to decrease the risk of allogeneic blood transfusion in the surgical setting. Roundtable of Experts in Surgery Blood Management.
Messmer K
Semin Hematol; 1996 Apr; 33(2 Suppl 2):78-80. PubMed ID: 8723589
[No Abstract] [Full Text] [Related]
32. Network: TUFH position paper. The ultimate challenge? Higher education for adapting to change and participating in managing change.
Christobal F; Engel CE; Talati J
Educ Health (Abingdon); 2009 Dec; 22(3):419. PubMed ID: 20029772
[No Abstract] [Full Text] [Related]
33. Transfusion of allogeneic blood products in proximal aortic surgery with hypothermic circulatory arrest: effect of thromboelastometry-guided transfusion management.
Fassl J; Matt P; Eckstein F; Filipovic M; Gregor M; Zenklusen U; Seeberger MD; Bolliger D
J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1181-8. PubMed ID: 23962459
[TBL] [Abstract][Full Text] [Related]
34. Blood management for patients with hemoglobin level lower than 130 g/l in total knee arthroplasty.
Minoda Y; Sakawa A; Fukuoka S; Tada K; Takaoka K
Arch Orthop Trauma Surg; 2004 Jun; 124(5):317-9. PubMed ID: 15060833
[TBL] [Abstract][Full Text] [Related]
35. Allogeneic blood transfusion as a risk factor for the subsequent development of non-Hodgkin's lymphoma.
Vamvakas EC
Transfus Med Rev; 2000 Jul; 14(3):258-68. PubMed ID: 10914420
[TBL] [Abstract][Full Text] [Related]
36. [Intraoperative blood requirements and allogeneic blood transfusion in cardioanesthesia. Data analysis of 7729 patients in 12 cardiac surgical clinics].
Dietrich W; Lüth JU; Kormann J; Wick S; Kaiser W; Eberle B; Karliczek F; Junger A; Gille A; Schwerdt M; Eleftheriadis S; Jaschik M
Anaesthesist; 1999 Dec; 48(12):876-83. PubMed ID: 10672351
[TBL] [Abstract][Full Text] [Related]
37. Allogeneic transfusion and infection: economic and clinical implications.
Blumberg N
Semin Hematol; 1997 Jul; 34(3 Suppl 2):34-40. PubMed ID: 9253782
[TBL] [Abstract][Full Text] [Related]
38. Integrative patient-centered care.
Guerrera MP; Glick RM; Benn R; Kemper K; Kligler B; Maizes V
J Altern Complement Med; 2008 Jun; 14(5):454. PubMed ID: 18564949
[No Abstract] [Full Text] [Related]
39. Transfusion strategy in multiple trauma patients.
Theusinger OM; Stein P; Spahn DR
Curr Opin Crit Care; 2014 Dec; 20(6):646-55. PubMed ID: 25314239
[TBL] [Abstract][Full Text] [Related]
40. Semi-allogeneic (F1) versus fully allogeneic blood transfusions: differences in their ability to induce specific immunological unresponsiveness.
Roelen DL; Dover EL; Niimi M; Young NT; Morris PJ; Wood KJ
Eur J Immunol; 1996 Jul; 26(7):1468-74. PubMed ID: 8766548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
